Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Share (Details)

v3.22.2.2
Note 11 - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Employee and Non-employee Stock Options [Member]        
Antidilutive Securities (in shares) 2,775,998 1,959,100 2,775,998 1,959,100
Warrant [Member]        
Antidilutive Securities (in shares) 265,000 265,000 265,000 265,000
Common Stock, Deferred Stock Units Settlement [Member]        
Antidilutive Securities (in shares) 134,402 71,509 134,402 71,509